Trade Summary

6 days ago, Scott Randal W., serving as Dir at Bridgebio Pharma, Inc. (BBIO), sold 10,000 shares at $67.15 per share, for a total transaction value of $671,456.00. Following this transaction, Scott Randal W. now holds 15,589 shares of BBIO.

This sale represents a 39.00% decrease in Scott Randal W.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:25 PM ET, 4 days after the trade was made.

Bridgebio Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.